BioCentury | Dec 23, 2020
Deals

Insilico caps year of deals by opening its computational platforms to pharmas’ in-house teams

...computational target discovery and chemistry technologies. On Dec. 22, the company announced a deal with Global Genomics...
BioCentury | Dec 22, 2020
Deals

Flagship’s Valo seeks cancer-like approach to CV drug development with G3 partnership

...biomarkers for cancer, neurodegeneration and cardiometabolic diseases.On Tuesday, Valo unveiled its partnership with multi-omics company Global Genomics...
...from Forma Therapeutics Inc. (NASDAQ:FMTX) in March; deal terms were not disclosed. Karen Tkach Tuzman Valo Health LLC Global Genomics...
BioCentury | Jul 30, 2019
Company News

How $2.8B Genomic Health deal catapults Exact beyond Cologuard

In a play to expand its international reach, its position with payers and its sales force, Exact Sciences is acquiring Genomic Health in a deal valued at $2.8 billion. The deal also helps accelerate a...
BioCentury | Nov 9, 2017
Emerging Company Profile

Network intelligence

...Zhang Patents: None issued Companies and Institutions Mentioned Verge Genomics Inc., San Francisco, Calif. Karen Tkach Tuzman Global Genomics...
BioCentury | Mar 3, 2016
Emerging Company Profile

SNP it all together

...extract the most useful and relevant information" for drug discovery. At least one other company, Global Genomics...
...individuals from studies that used differing protocols. Companies and Institutions Mentioned Genomics plc, Oxford, U.K. Global Genomics...
BioCentury | Feb 11, 2016
Tools & Techniques

-Omics overdrive

...Over the past five years, Global Genomics Group LLC (G3) has been steadily amassing and analyzing pan-omics...
...are starting the commercialization process and identifying the right distribution partners." Companies and Institutions Mentioned Global Genomics...
...Reproduced with permission from Global Genomics Group LLC Hearts exposed In its GLOBAL clinical study, Global Genomics...
BioCentury | May 12, 2014
Company News

Global Genomics Group management update

Global Genomics Group LLC , Richmond, Va. Business: Genomics, Bioinformatics, Diagnostic Hired: Harry Davis as chief drug development officer, while remaining CSO of CVPath Institute WIR Staff...
BioCentury | Mar 3, 2014
Company News

Caprion Proteomics, Global Genomics Group, Quintiles deal

...details. Separately, Global Genomics and Caprion said Caprion will identify blood-based protein markers for the study. Global Genomics...
...details. Separately, Global Genomics and Caprion said Caprion will identify blood-based protein markers for the study. Global Genomics...
...Cardiovascular Global Genomics is funding the study and conducting it with Health Diagnostic Laboratory (Richmond, Va.). Global Genomics...
BioCentury | Nov 25, 2013
Company News

Global Genomics Group, Health Diagnostic Laboratory, Metabolon deal

...artery disease (CAD). Global Genomics is funding the study and conducting it with Health Diagnostic Laboratory. Global Genomics...
...for suspected CAD in Phase I and may extend to 10,000 patients in Phase II. Global Genomics...
...4Q14, with bioinformatics results slated for 2015. Global Genomics and Metabolon declined to disclose financial terms. Global Genomics...
BioCentury | Sep 30, 2013
Company News

Global Genomics Group, Health Diagnostic Laboratory, Illumina deal

...artery disease (CAD). Global Genomics is funding the study and conducting it with Health Diagnostic Laboratory. Global Genomics...
...up to 7,000 subjects who are clinically referred for coronary CT angiography for suspected CAD. Global Genomics...
...data are expected in spring or summer of 2014, with bioinformatics results slated for 2015. Global Genomics...
Items per page:
1 - 10 of 21
BioCentury | Dec 23, 2020
Deals

Insilico caps year of deals by opening its computational platforms to pharmas’ in-house teams

...computational target discovery and chemistry technologies. On Dec. 22, the company announced a deal with Global Genomics...
BioCentury | Dec 22, 2020
Deals

Flagship’s Valo seeks cancer-like approach to CV drug development with G3 partnership

...biomarkers for cancer, neurodegeneration and cardiometabolic diseases.On Tuesday, Valo unveiled its partnership with multi-omics company Global Genomics...
...from Forma Therapeutics Inc. (NASDAQ:FMTX) in March; deal terms were not disclosed. Karen Tkach Tuzman Valo Health LLC Global Genomics...
BioCentury | Jul 30, 2019
Company News

How $2.8B Genomic Health deal catapults Exact beyond Cologuard

In a play to expand its international reach, its position with payers and its sales force, Exact Sciences is acquiring Genomic Health in a deal valued at $2.8 billion. The deal also helps accelerate a...
BioCentury | Nov 9, 2017
Emerging Company Profile

Network intelligence

...Zhang Patents: None issued Companies and Institutions Mentioned Verge Genomics Inc., San Francisco, Calif. Karen Tkach Tuzman Global Genomics...
BioCentury | Mar 3, 2016
Emerging Company Profile

SNP it all together

...extract the most useful and relevant information" for drug discovery. At least one other company, Global Genomics...
...individuals from studies that used differing protocols. Companies and Institutions Mentioned Genomics plc, Oxford, U.K. Global Genomics...
BioCentury | Feb 11, 2016
Tools & Techniques

-Omics overdrive

...Over the past five years, Global Genomics Group LLC (G3) has been steadily amassing and analyzing pan-omics...
...are starting the commercialization process and identifying the right distribution partners." Companies and Institutions Mentioned Global Genomics...
...Reproduced with permission from Global Genomics Group LLC Hearts exposed In its GLOBAL clinical study, Global Genomics...
BioCentury | May 12, 2014
Company News

Global Genomics Group management update

Global Genomics Group LLC , Richmond, Va. Business: Genomics, Bioinformatics, Diagnostic Hired: Harry Davis as chief drug development officer, while remaining CSO of CVPath Institute WIR Staff...
BioCentury | Mar 3, 2014
Company News

Caprion Proteomics, Global Genomics Group, Quintiles deal

...details. Separately, Global Genomics and Caprion said Caprion will identify blood-based protein markers for the study. Global Genomics...
...details. Separately, Global Genomics and Caprion said Caprion will identify blood-based protein markers for the study. Global Genomics...
...Cardiovascular Global Genomics is funding the study and conducting it with Health Diagnostic Laboratory (Richmond, Va.). Global Genomics...
BioCentury | Nov 25, 2013
Company News

Global Genomics Group, Health Diagnostic Laboratory, Metabolon deal

...artery disease (CAD). Global Genomics is funding the study and conducting it with Health Diagnostic Laboratory. Global Genomics...
...for suspected CAD in Phase I and may extend to 10,000 patients in Phase II. Global Genomics...
...4Q14, with bioinformatics results slated for 2015. Global Genomics and Metabolon declined to disclose financial terms. Global Genomics...
BioCentury | Sep 30, 2013
Company News

Global Genomics Group, Health Diagnostic Laboratory, Illumina deal

...artery disease (CAD). Global Genomics is funding the study and conducting it with Health Diagnostic Laboratory. Global Genomics...
...up to 7,000 subjects who are clinically referred for coronary CT angiography for suspected CAD. Global Genomics...
...data are expected in spring or summer of 2014, with bioinformatics results slated for 2015. Global Genomics...
Items per page:
1 - 10 of 21